Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 26.06.2023       M1 Kliniken AG
First Berlin Equity Research GmbH DE000A0STSQ8

First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 10,50. Zusammenfassung: Die Q1-Hauptkennzahlen zeigen, dass das Beauty-Geschäft von M1 weiter an Dynamik gewinnt und die Erträ [ … ]
Technical analysis
To the publication
Mon, 26.06.2023       M1 Kliniken AG
First Berlin Equity Research GmbH DE000A0STSQ8

First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 10,50. Zusammenfassung: Die Q1-Hauptkennzahlen zeigen, dass das Beauty-Geschäft von M1 weiter an Dynamik gewinnt und die Erträ [ … ]
Technical analysis
To the publication
Thu, 22.06.2023       Aspermont Ltd
GBC AG AU000000ASP3

Growth even facing headwinds market conditions. Renowned top executive and management hiring. Forecast focus on return to double digit growth.   Facing headwinds but growing. The revenues are up 1% YoY, reaching $9.36m AUD. Revenues are in line with company’s guidance.   Increased net liquidity asset. The company has a net liquidi [ … ]
Technical analysis
To the publication
Thu, 22.06.2023       Aspermont Ltd
GBC AG AU000000ASP3

Growth even facing headwinds market conditions. Renowned top executive and management hiring. Forecast focus on return to double digit growth.   Facing headwinds but growing. The revenues are up 1% YoY, reaching $9.36m AUD. Revenues are in line with company’s guidance.   Increased net liquidity asset. The company has a net liquidi [ … ]
Technical analysis
To the publication
Wed, 21.06.2023       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00. Zusammenfassung: Haemato hat das Jahr mit einem starken ersten Quartal begonnen und ist auf gutem Weg, unsere Ziele fü [ … ]
Technical analysis
To the publication
Wed, 21.06.2023       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00. Zusammenfassung: Haemato hat das Jahr mit einem starken ersten Quartal begonnen und ist auf gutem Weg, unsere Ziele fü [ … ]
Technical analysis
To the publication
Tue, 20.06.2023       Media and Games Invest SE
GBC AG SE0018538068

Financial year 2022 closed with a significant improvement in revenue and operating profit; A continuation of the profitable growth course is expected for 2023; The expansion of the ad tech platform business should lead to significant revenue and earnings growth in the future; Target price: € 5.30 (previously: € 5.40); Rating: BUY    [ … ]
Technical analysis
To the publication
Tue, 20.06.2023       Media and Games Invest SE
GBC AG SE0018538068

Financial year 2022 closed with a significant improvement in revenue and operating profit; A continuation of the profitable growth course is expected for 2023; The expansion of the ad tech platform business should lead to significant revenue and earnings growth in the future; Target price: € 5.30 (previously: € 5.40); Rating: BUY    [ … ]
Technical analysis
To the publication
Mon, 19.06.2023       Knaus Tabbert AG
First Berlin Equity Research GmbH DE000A2YN504

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 71,00 auf EUR 75,00. Zusammenfassung: Knaus Tabbert veranstaltete seinen Capital Markets Day in Bayern, der Folgendes umfasste: (1) eine B [ … ]
Technical analysis
To the publication
Mon, 19.06.2023       Knaus Tabbert AG
First Berlin Equity Research GmbH DE000A2YN504

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 71,00 auf EUR 75,00. Zusammenfassung: Knaus Tabbert veranstaltete seinen Capital Markets Day in Bayern, der Folgendes umfasste: (1) eine B [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 24.11.2024, Calendar Week 47, 329th day of the year, 37 days remaining until EoY.